PMID- 18564209
OWN - NLM
STAT- MEDLINE
DCOM- 20090303
LR  - 20181201
IS  - 1610-0387 (Electronic)
IS  - 1610-0379 (Linking)
VI  - 6
IP  - 10
DP  - 2008 Oct
TI  - Subacute cutaneous lupus erythematosus induced by terbinafine: case report and 
      review of literature.
PG  - 823-7, 823-8
LID - 10.1111/j.1610-0387.2008.06806.x [doi]
AB  - Systemic lupus erythematosus and subacute cutaneous lupus erythematosus (SCLE) 
      occasionally evolve as adverse reactions to a large variety of chemically 
      different drugs. We here report on a 76-year-old woman who developed SCLE within 
      10 days after initiation of oral terbinafine. Analysis of the 27 cases of 
      terbinafine-induced SCLE in the literature revealed that this disorder has been 
      reported 6 times more often in females than in males. Skin lesions evolved on 
      average around 7 weeks after starting the drug. In 79% of the cases ANA could be 
      detected while antibodies against Ro/SS-A and La/SS-B were found in 86% and 39%, 
      respectively. Remarkably, anti-histone antibodies were present in only 29%. In 
      all cases terbinafine-induced SCLE resolved after discontinuation of the 
      triggering agent. Systemic treatment with anti-malarials and/or corticosteroids 
      does not appear to be mandatory.
FAU - Lorentz, Katharina
AU  - Lorentz K
AD  - Department of Dermatology, University Clinic of Mannheim, Medical School of 
      Mannheim at the University of Heidelberg, Germany.
FAU - Booken, Nina
AU  - Booken N
FAU - Goerdt, Sergij
AU  - Goerdt S
FAU - Goebeler, Matthias
AU  - Goebeler M
LA  - eng
LA  - ger
PT  - Case Reports
PT  - Journal Article
PT  - Review
DEP - 20080617
PL  - Germany
TA  - J Dtsch Dermatol Ges
JT  - Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German 
      Society of Dermatology : JDDG
JID - 101164708
RN  - 0 (Antifungal Agents)
RN  - 0 (Naphthalenes)
RN  - G7RIW8S0XP (Terbinafine)
SB  - IM
MH  - Acute Disease
MH  - Aged
MH  - Antifungal Agents/*adverse effects
MH  - Drug Eruptions/*diagnosis/*etiology/therapy
MH  - Female
MH  - Humans
MH  - Lupus Erythematosus, Cutaneous/*chemically induced/*diagnosis/therapy
MH  - Naphthalenes/*adverse effects
MH  - Terbinafine
RF  - 17
EDAT- 2008/06/20 09:00
MHDA- 2009/03/04 09:00
CRDT- 2008/06/20 09:00
PHST- 2008/06/20 09:00 [pubmed]
PHST- 2009/03/04 09:00 [medline]
PHST- 2008/06/20 09:00 [entrez]
AID - DDG06806 [pii]
AID - 10.1111/j.1610-0387.2008.06806.x [doi]
PST - ppublish
SO  - J Dtsch Dermatol Ges. 2008 Oct;6(10):823-7, 823-8. doi: 
      10.1111/j.1610-0387.2008.06806.x. Epub 2008 Jun 17.